Intrinsiqq
Amkor Technology Inc. logo

Amkor Technology Inc. (AMKR) Insider Trading

Last 12 months

Insiders sold $22.4M and bought nothing on the open market.

29% of the selling was scheduled in advance under 10b5-1 plans. Director Guillaume Marie Jean Rutten sold $3.71M on May 8, 9.0% of their stake, outside a plan. The last open-market buy by an executive or director was in Aug 2025.

Net open-market
−$22.4M
0 buys · 38 sales
Under a 10b5-1 plan
29%
of the value sold
Insiders who bought / sold
0 / 10
executives and directors
Last open-market buy
Aug 2025
Aug 1, 2025

Get an email when AMKR's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Oct 1310b5-1 plan
    Megan Faust
    CFO · sold 1,000 at $46.92
    $47k
    0.7% of stake
  • Oct 210b5-1 plan
    Douglas A Alexander
    Director · sold 5,000 at $55.00
    $275k
    15% of stake
  • Sep 810b5-1 plan
    Megan Faust
    CFO · sold 1,000 at $49.05
    $49k
    0.7% of stake
  • Aug 1710b5-1 plan
    Mark N Rogers
    EVP & General Counsel · sold 5,000 at $59.78
    $299k
    11% of stake
  • Aug 1110b5-1 plan
    Megan Faust
    CFO · sold 1,000 at $54.45
    $54k
    0.7% of stake
  • Aug 710b5-1 plan
    Douglas A Alexander
    Director · sold 5,000 at $55.81
    $279k
    15% of stake
  • Aug 5 – 6No plan
    Guillaume Marie Jean Rutten
    Director · sold 50,000 at avg $54.93
    $2.75M
    9.8% of stake
  • Jul 30No plan
    Kevin K. Engel
    President and CEO · sold 3,221 at $47.00
    $151k
    25% of stake
  • Jul 1610b5-1 plan
    Mark N Rogers
    EVP & General Counsel · sold 5,000 at $65.12
    $326k
    11% of stake
  • Jul 1410b5-1 plan
    Megan Faust
    CFO · sold 1,000 at $69.91
    $70k
    0.7% of stake
  • Jun 1610b5-1 plan
    Mark N Rogers
    EVP & General Counsel · sold 5,000 at $86.21
    $431k
    11% of stake
  • Jun 12No plan
    Winston J Churchill
    Director · sold 5,000 at $78.20
    $391k
    15% of stake
  • Jun 910b5-1 plan
    Megan Faust
    CFO · sold 1,000 at $70.30
    $70k
    0.8% of stake
  • May 1910b5-1 plan
    Megan Faust
    CFO · sold 1,000 at $64.60
    $65k
    0.7% of stake
  • May 1810b5-1 plan
    Mark N Rogers
    EVP & General Counsel · sold 5,000 at $71.63
    $358k
    11% of stake
  • May 11No plan
    Gil C. Tily
    Director · sold 15,000 at $77.30
    $1.16M
    12% of stake
  • May 8No plan
    Guillaume Marie Jean Rutten
    Director · sold 50,000 at $74.28
    $3.71M
    9.0% of stake
  • May 5No plan
    Roger Anthony Carolin
    Director · sold 20,000 at $76.24
    $1.52M
    17% of stake
  • May 5No plan
    Winston J Churchill
    Director · sold 7,000 at $76.45
    $535k
    27% of stake
  • May 5No plan
    Douglas A Alexander
    Director · sold 5,000 at avg $76.58
    $383k
    15% of stake
  • Apr 1610b5-1 plan
    Mark N Rogers
    EVP & General Counsel · sold 5,000 at $59.43
    $297k
    11% of stake
  • Mar 1610b5-1 plan
    Mark N Rogers
    EVP & General Counsel · sold 5,000 at $44.54
    $223k
    11% of stake
  • Feb 25No plan
    Farshad Haghighi
    Executive Vice President · sold 15,624 at $50.50
    $789k
    65% of stake
  • Feb 24No plan
    Kevin K. Engel
    President and CEO · sold 12,500 at $48.75
    $609k
    81% of stake
  • Feb 24No plan
    Guillaume Marie Jean Rutten
    Director · sold 20,000 at $48.80
    $976k
    3.5% of stake
  • Feb 1710b5-1 plan
    Guillaume Marie Jean Rutten
    Director · sold 10,000 at $45.89
    $459k
    2.9% of stake
  • Feb 17No plan
    Kevin K. Engel
    President and CEO · sold 5,316 at $46.03
    $245k
    87% of stake
  • Feb 1710b5-1 plan
    Mark N Rogers
    EVP & General Counsel · sold 5,000 at $46.92
    $235k
    17% of stake
  • Feb 12No plan
    915 Investments, LP
    Large holder · sold 10,000,000 at $48.49
    $485M
    25% of stake
  • Feb 12No plan
    John T Kim
    Large holder · sold 10,000,000 at $48.49
    $485M
    10% of stake
  • Jan 1610b5-1 plan
    Mark N Rogers
    EVP & General Counsel · sold 5,000 at $49.28
    $246k
    17% of stake
  • Jan 1510b5-1 plan
    Guillaume Marie Jean Rutten
    Director · sold 10,000 at $53.14
    $531k
    2.9% of stake
  • Dec 16, 202510b5-1 plan
    Mark N Rogers
    EVP & General Counsel · sold 20,000 at $42.95
    $859k
    46% of stake
  • Dec 15, 2025No plan
    Winston J Churchill
    Director · sold 5,000 at $44.29
    $221k
    16% of stake
  • Dec 15, 202510b5-1 plan
    Guillaume Marie Jean Rutten
    President and CEO · sold 10,000 at $44.80
    $448k
    2.9% of stake
  • Dec 12, 2025No plan
    Maryfrances McCourt
    Director · sold 20,000 at $46.02
    $920k
    26% of stake
  • Dec 12, 2025No plan
    Kevin Engel
    Executive Vice President · sold 11,000 at $46.21
    $508k
    97% of stake
  • Dec 12, 2025No plan
    Gil C. Tily
    Director · sold 20,000 at $46.44
    $929k
    14% of stake
  • Nov 17, 202510b5-1 plan
    Guillaume Marie Jean Rutten
    President and CEO · sold 10,000 at $31.68
    $317k
    2.8% of stake
  • Nov 17, 202510b5-1 plan
    Mark N Rogers
    EVP & General Counsel · sold 20,000 at $31.69
    $634k
    46% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch AMKR, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Semiconductors & Related Devices

Spot a number that looks wrong? Check it in AMKR's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing AMKR

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.